Collaborations & Alliances
Filter by:
421 - 435 of 1484 results
April 16, 2013
Will initially develop and commercialize six products
Read More »
April 15, 2013
Aims to identify novel small molecule and antibody targets
Read More »
April 11, 2013
Five-year pact covers central lab work, biomarker testing and assay development
Read More »
April 11, 2013
Dalton to synthesize and manufacture selected drug candidates
Read More »
April 9, 2013
Acquires rights to Tykerb in China
Read More »
April 8, 2013
Regains all commercialization rights
Read More »
April 5, 2013
Will use conjugation technology to develop ADCs in oncology
Read More »
April 5, 2013
Will evaluate VX-135 and daclatasvir in hepatitis C
Read More »
April 4, 2013
To develop novel antibody program from X-BODY platform
Read More »
April 4, 2013
To develop CHO cell lines and assess product attributes for proteins
Read More »
April 3, 2013
Gains access to Captisol technology
Read More »
April 3, 2013
Will develop and commercialize multiple Accurins
Read More »
April 2, 2013
Will use Tetragenetics technology platform for antibody production
Read More »
April 2, 2013
Extreme Diversity platform will help develop candidates
Read More »
421 - 435 of 1484 results
